1. We test eligibility
Category, US availability, practice size, specialty, primary use case, critical integrations, budget feasibility and implementation timing can remove or down-rank a product. Popularity alone never makes a vendor eligible.
2. We rank decision fit
Verified functional fit and critical integrations carry the most weight, followed by total-cost fit, stack coherence, small-practice fit, evidence quality and timeline. A commercial relationship can only act as a small tiebreaker among already-eligible products.
3. We grade the evidence
Official vendor pricing outranks independent estimates. Buyer-reported prices are labeled as anecdotal ranges. For integrations, we record a named source, target, workflow and mechanism; a logo wall is not treated as proof that billing or clinical data moves correctly.
4. We leave unknowns unknown
Quote-only prices, implementation fees and unverified interfaces remain visible as gaps. Recommendations show decision-specific checks only when the buyer’s answers make them relevant.
Review cycle
The current medical-software dataset was reviewed July 18, 2026. Product pages show source links so buyers can recheck time-sensitive facts before signing a contract.